Healthcare Innovations, 11
Back to All Secondary TrustsPortfolio Holdings by Security (As of Deposit Date)
Ticker | Security Description | Deposit % |
---|---|---|
ACAD | ACADIA Pharmaceuticals Inc. | 3.31 |
AGIO | Agios Pharmaceuticals, Inc. | 3.31 |
ARCT | Arcturus Therapeutics Holdings Inc. | 3.37 |
ARQT | Arcutis Biotherapeutics, Inc. | 3.32 |
ATRA | Atara Biotherapeutics, Inc. | 3.31 |
AUPH | Aurinia Pharmaceuticals Inc. | 3.29 |
AXSM | Axsome Therapeutics, Inc. | 3.36 |
BHVN | Biohaven Pharmaceutical Holding Company Ltd. | 3.30 |
BLUE | bluebird bio, Inc. | 3.36 |
BTAI | BioXcel Therapeutics, Inc. | 3.32 |
CNST | Constellation Pharmaceuticals, Inc. | 3.36 |
CRTX | Cortexyme, Inc. | 3.20 |
DCPH | Deciphera Pharmaceuticals, Inc. | 3.33 |
EPZM | Epizyme, Inc. | 3.33 |
GBT | Global Blood Therapeutics, Inc. | 3.34 |
IMVT | Immunovant, Inc. | 3.38 |
INO | Inovio Pharmaceuticals, Inc. | 3.34 |
KNSA | Kiniksa Pharmaceuticals, Ltd. | 3.38 |
KPTI | Karyopharm Therapeutics Inc. | 3.51 |
MCRB | Seres Therapeutics, Inc. | 3.31 |
MDGL | Madrigal Pharmaceuticals, Inc. | 3.32 |
MESO | Mesoblast Limited | 3.34 |
MGNX | MacroGenics, Inc. | 3.28 |
MYOV | Myovant Sciences Ltd. | 3.40 |
REPL | Replimune Group, Inc. | 3.34 |
RETA | Reata Pharmaceuticals, Inc. | 3.28 |
RGNX | REGENXBIO Inc. | 3.28 |
RYTM | Rhythm Pharmaceuticals, Inc. | 3.35 |
SRPT | Sarepta Therapeutics, Inc. | 3.37 |
ZGNX | Zogenix, Inc. | 3.31 |
Health Care
Ticker | Security Description | Deposit % |
---|---|---|
ACAD | ACADIA Pharmaceuticals Inc. | 3.31 |
AGIO | Agios Pharmaceuticals, Inc. | 3.31 |
ARCT | Arcturus Therapeutics Holdings Inc. | 3.37 |
ARQT | Arcutis Biotherapeutics, Inc. | 3.32 |
ATRA | Atara Biotherapeutics, Inc. | 3.31 |
AUPH | Aurinia Pharmaceuticals Inc. | 3.29 |
AXSM | Axsome Therapeutics, Inc. | 3.36 |
BHVN | Biohaven Pharmaceutical Holding Company Ltd. | 3.30 |
BTAI | BioXcel Therapeutics, Inc. | 3.32 |
BLUE | bluebird bio, Inc. | 3.36 |
CNST | Constellation Pharmaceuticals, Inc. | 3.36 |
CRTX | Cortexyme, Inc. | 3.20 |
DCPH | Deciphera Pharmaceuticals, Inc. | 3.33 |
EPZM | Epizyme, Inc. | 3.33 |
GBT | Global Blood Therapeutics, Inc. | 3.34 |
IMVT | Immunovant, Inc. | 3.38 |
INO | Inovio Pharmaceuticals, Inc. | 3.34 |
KPTI | Karyopharm Therapeutics Inc. | 3.51 |
KNSA | Kiniksa Pharmaceuticals, Ltd. | 3.38 |
MGNX | MacroGenics, Inc. | 3.28 |
MDGL | Madrigal Pharmaceuticals, Inc. | 3.32 |
MESO | Mesoblast Limited | 3.34 |
MYOV | Myovant Sciences Ltd. | 3.40 |
RETA | Reata Pharmaceuticals, Inc. | 3.28 |
RGNX | REGENXBIO Inc. | 3.28 |
REPL | Replimune Group, Inc. | 3.34 |
RYTM | Rhythm Pharmaceuticals, Inc. | 3.35 |
SRPT | Sarepta Therapeutics, Inc. | 3.37 |
MCRB | Seres Therapeutics, Inc. | 3.31 |
ZGNX | Zogenix, Inc. | 3.31 |
Summary
Description
-
Trust Name Healthcare Innovations, 11
-
Trust Symbol SMHCKX
-
MS Symbol STHC11
Deposit Data
-
Deposit Date 05/04/2021
-
Termination Date 20230504
-
Minimum Investment 100
-
Distribution Frequency Monthly (if any)
-
Initial Public Offer Price $10.00
-
Historical 12-Month Dist.* 0.0000
CUSIP
-
Cash Cusip 83192X309
-
Reinvest Cusip 83192X317
-
Fee Cash Cusip 83192X325
-
Fee Invest Cusip 83192X333
Documents
*The Historical 12-Month Distribution of Trust Holdings is as of 10/01/2024. If the Trust deposited after, or 90 days prior to, 10/01/2024, the distribution is as of deposit date. The Historical 12-Month Distribution is calculated by taking the weighted average of the regular income distributions paid by the securities included in the trust’s portfolio over the 12 months preceding the trust’s date of deposit reduced to account for the effects of trust fees and expenses. This historical distribution is for illustrative purposes only and is not indicative of amounts that will actually be distributed by the trust. The distributions paid by the trust may be higher or lower than the amount shown above due to factors including, but not limited to, changes in the price of trust units, changes (including reductions) in distributions paid by issuers, changes in actual trust expenses and sales of securities in the portfolio. There is no guarantee that the issuers of the securities included in the trust will pay any distributions in the future.